0.00Open0.00Pre Close0 Volume0 Open Interest64.00Strike Price0.00Turnover7255.10%IV-17.09%PremiumDec 13, 2024Expiry Date13.19Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9275Delta0.0133Gamma5.96Leverage Ratio-554.9879Theta0.0000Rho5.53Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet